Browse by all authors Browse By Author ID - Harding, Angus

Browse Results (26 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set


  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Harding, Angus Silas (2004). A biochemical analysis of the MAP kinase pathway in mammalian cells PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. 1586 9
Inder, K., Harding, A., Plowman, S. J., Philips, M. R., Parton, R. G. and Hancock, J. F. (2008) Activation of the MAPK Module from Different Spatial Locations Generates Distinct System Outputs. Molecular Biology of the Cell, 19 11: 4776-4784. doi:10.1091/mbc.E08-04-0407 30   38 Cited 43 times in Scopus43 0
Lim, Yi Chieh, Roberts, Tara L., Day, Bryan W., Harding, Angus, Kozlov, Sergei, Kijas, Amanda W., Ensbey, Kathleen S., Walker, David G. and Lavin, Martin F. (2012) A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells. Molecular Cancer Therapeutics, 11 9: 1863-1872. doi:10.1158/1535-7163.MCT-11-1044 51   9 Cited 9 times in Scopus9 1
Gabrielli, B., Chau, Y. Q., Giles, N., Harding, A., Stevens, F. and Beamish, H. (2007) Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells. The Journal of Biological Chemistry, 282 10: 6954-6964. doi:10.1074/jbc.M610104200 104   23 Cited 24 times in Scopus24 0
Roy, S., Luetterforst, R., Harding, A., Apolloni, A., Etheridge, M., Stang, E., Rolls, B., Hancock, J. F. and Parton, R. G. (1999) Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nature Cell Biology, 1 2: 98-105. 94   345
Day, Bryan W., Stringer, Brett W., Al-Ejeh, Fares, Ting, Michael J., Wilson, John, Ensbey, Kathleen S., Jamieson, Paul R., Bruce, Zara C., Lim, Yi Chieh, Offenhauser, Carolin, Charmsaz, Sara, Cooper, Leanne T., Ellacott, Jennifer K., Harding, Angus, Leveque, Lucie, Inglis, Po, Allan, Suzanne, Walker, David G., Lackmann, Martin, Osborne, Geoffrey, Khanna, Kum Kum, Reynolds, Brent A., Lickliter, Jason D. and Boyd, Andrew W. (2013) EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme. Cancer Cell, 23 2: 238-248. doi:10.1016/j.ccr.2013.01.007 63   24 Cited 26 times in Scopus26 13
Deleyrolle, Loic P., Harding, Angus, Cato, Kathleen, Siebzehnrubl, Florian A., Rahman, Maryam, Azari, Hassan, Olson, Sarah, Gabrielli, Brian, Osborne, Geoffrey, Vescovi, Angelo and Reynolds, Brent A. (2011) Evidence for label-retaining tumour-initiating cells in human glioblastoma. Brain, 134 5: 1331-1343. doi:10.1093/brain/awr081 68   25 Cited 31 times in Scopus31 0
Jayalath, R., Donovan, P., Cato, K., Olsson, G., Hall, B., Olson, S., Reynolds, B. and Harding, A. (2012). Glioblastoma tumours can harbour a subset of polyploid cells that are resistant to conventional therapy and may increase the adaptive capacity of patient tumours. In: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting, Brisbane, QLD, Australia, (63-63). 8-10 August 2012. doi:10.1111/j.1743-7563.2012.01586_2.x 50   0 0
Prior, Ian A., Harding, Angus, Yan, Jun, Sluimer, Judith, Parton, Robert G. and Hancock, John F. (2001) GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nature Cell Biology, 3 4: 368-375. doi:10.1038/35070050 68   335 Cited 338 times in Scopus338 0
Tian, Tianhai and Harding, Angus (2014) How MAP kinase modules function as robust, yet adaptable, circuits. Cell Cycle, 13 15: 2379-2390. doi:10.4161/cc.29349 9   0 Cited 0 times in Scopus0 1
Harding, A., Hsu, V., Kornfeld, K. and Hancock, J. F. (2003) Identification of residues and domains of Raf important for function in vivo and in vitro. Journal of Biological Chemistry, 278 46: 45519-45527. doi:10.1074/jbc.M303106200 32   11 Cited 14 times in Scopus14 0
McPherson, R. A., Harding, A. S., Roy, S., Lane, A. C., Hancock, J. F. and Sandrine, R (1999) Interactions of c-Raf-1 with phosphatidylserine and 14-3-3. Oncogene, 18 26: 3862-3869. doi:10.1038/sj.onc.1202730 22   49 Cited 47 times in Scopus47 0
Lin, Joseph, Angus Harding, Giurisato, Emanuele and Shaw, Andrey S. (2009) KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs. Molecular and Cellular Biology, 29 8: 2082-2091. doi:10.1128/MCB.01634-08 48   24 Cited 27 times in Scopus27 0
Lim, Yi Chieh, Roberts, Tara, Harding, Angus, Day, Bryan, Kozlov, Sergei, Walker, David and Lavin, Martin (2008) Low dose ionizing radiation responses and knockdown of ATM kinase activity in glioma stem cells. Acta Medica Nagasakiensia, 53 Suppl.: 37-43. 22   Cited 0 times in Scopus0
Astuti, P, Pike, T, Widberg, C, Payne, E, Harding, A, Hancock, J and Gabrielli, B (2009) MAPK pathway activation delays G(2)/M progression by destabilizing Cdc25B. Journal of Biological Chemistry, 284 49: 33781-33788. doi:10.1074/jbc.M109.027516 86   14 Cited 15 times in Scopus15 0
Harding, A., Giles, N., Burgess, A., Hancock, J. F. and Gabrielli, B. G. (2003) Mechanism of mitosis-specific activation of MEK1. Journal of Biological Chemistry, 278 19: 16747-16754. doi:10.1074/jbc.M301015200 49   39 Cited 40 times in Scopus40 0
Maxwell, M. A., Cleasby, M. E., Harding, A., Stark, A., Cooney, G. J. and Muscat, G. E. O. (2005) Nur77 regulates lipolysis in skeletal muscle cells - Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. Journal Of Biological Chemistry, 280 13: 12573-12584. doi:10.1074/jbc.M40950200 109   83 Cited 84 times in Scopus84 0
Tian, T. H., Harding, A., Inder, K., Plowman, S., Parton, R. G. and Hancock, J. F. (2007) Plasma membrane nanoswitches generate high-fidelity Ras signal transduction. Nature Cell Biology, 9 8: 905-914. doi:10.1038/ncb1615 72   147 Cited 155 times in Scopus155 0
Harding, A. and Hancock, J. F. (2008) Ras nanoclusters: combining digital and analog signaling. Cell Cycle, 7 2: 127-134. 69   34 Cited 35 times in Scopus35
Plowman, S., Harding, A., Tinhai, T., Parton, R. G. and Hancock, J. F. (2006). Ras Plasma Membrane Signaling Platforms. In: Neurosignals: (ASI):Signaling in Cell Growth and Differentiation. Croucher Advanced Study Institute (ASI):Signaling in Cell Growth and Differentiation, Hong Kong, (48-48). 16-20 January, 2006. doi:10.1159/000094386 50   0 0
Lim, Y. C., Roberts, T., Day, B., Harding, A., Ensbey, K., Kozlov, S., Kijas, A., Walker, D. and Lavin, M. (2012). Response of glioma initiating cells to ionising radiation. In: Targeting Cancer from Diagnosis to Cure & 5th Annual COGNO Annual Scientific Meeting, Brisbane, QLD, Australia, (64-64). 8-10 August 2012. doi:10.1111/j.1743-7563.2012.01586_2.x 23   0 0
Harding, A., Tian, T. H., Westbury, E., Frische, E. and Hancock, J. F. (2005) Subcellular localization determines MAP kinase signal output. Current Biology, 15 9: 869-873. doi:10.1016/j.cub.2005.04.020 47   89 Cited 97 times in Scopus97 1
Whitacre, James M., Lin, Joseph and Harding, Angus (2012) T cell adaptive immunity proceeds through environment-induced adaptation from the exposure of cryptic genetic variation. Frontiers in Genetics, 3 . doi:10.3389/fgene.2012.00005 10   Cited 3 times in Scopus3 0
Giurisato, E., Lin, J., Harding, Angus, Cerutti, E., Cella, M, Lewis, R. E., Colonna, M. and Shaw, A. S. (2009) The mitogen-activated protein kinase scaffold KSR1 is required for recruitment of extracellular signal-regulated kinase to the immunological synapse. Molecular And Cellular Biology, 29 6: 1554-1564. doi:10.1128/MCB.01421-08 35   13 Cited 14 times in Scopus14 0
Tian, Tianhai, Olson, Sarah, Whitacre, James M. and Harding, Angus (2011) The origins of cancer robustness and evolvability. Integrative Biology, 3 1: 17-30. doi:10.1039/c0ib00046a 70 89 22 Cited 29 times in Scopus29 9
Harding, A. and Hancock, J. F. (2008) Using plasma membrane nanoclusters to build better signaling circuits. Trends In Cell Biology, 18 8: 364-371. doi:10.1016/j.tcb.2008.05.006 35   53 Cited 53 times in Scopus53 0